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Disruption of the temporally regulated cloaca
endodermal b-catenin signaling causes anorectal
malformations
S Miyagawa1,2,3,8, M Harada1,2,4,8, D Matsumaru1,2,8, K Tanaka1,2, C Inoue1,2, C Nakahara1,2, R Haraguchi1,2,5, S Matsushita1,
K Suzuki1,2, N Nakagata6, RC-L Ng7, K Akita4, VC-H Lui7 and G Yamada*,1,2
The cloaca is temporally formed and eventually divided by the urorectal septum (URS) during urogenital and anorectal organ
development. Although congenital malformations, such as anorectal malformations (ARMs), are frequently observed during this
process, the underlying pathogenic mechanisms remain unclear. b-Catenin is a critical component of canonical Wnt signaling
and is essential for the regulation of cell differentiation and morphogenesis during embryogenesis. The expression of b-catenin
is observed in endodermal epithelia, including URS epithelia. We modulated the b-catenin gene conditionally in endodermal
epithelia by utilizing tamoxifen-inducible Cre driver line (ShhCreERT2). Both b-catenin loss- and gain-of-function (LOF and GOF)
mutants displayed abnormal clefts in the perineal region and hypoplastic elongation of the URS. The mutants also displayed
reduced cell proliferation in the URS mesenchyme. In addition, the b-catenin GOF mutants displayed reduced apoptosis and
subsequently increased apoptosis in the URS epithelium. This instability possibly resulted in reduced expression levels of
differentiation markers, such as keratin 1 and filaggrin, in the perineal epithelia. The expression of bone morphogenetic protein
(Bmp) genes, such as Bmp4 and Bmp7, was also ectopically induced in the epithelia of the URS in the b-catenin GOF mutants.
The expression of the Msx2 gene and phosphorylated-Smad1/5/8, possible readouts of Bmp signaling, was also increased in the
mutants. Moreover, we introduced an additional mutation for a Bmp receptor gene: BmprIA. The ShhCreERT2/þ ; b-cateninflox(ex3)/þ ;
BmprIAflox/ mutants displayed partial restoration of URS elongation compared with the b-catenin GOF mutants. These results
indicate that some ARM phenotypes in the b-catenin GOF mutants were caused by abnormal Bmp signaling. The current analysis
revealed the close relation of endodermal b-catenin signaling to the ARM phenotypes. These results are considered to shed light on
the pathogenic mechanisms of human ARMs.
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During embryonic development, the cloaca is a temporal
structure that is subsequently divided into the urogenital sinus
and rectum by the urorectal septum (hereafter referred to as
the URS).1–3 The URS develops from the proximal umbilical
mesenchyme (the rostral portion of the cloaca) around
embryonic day 10.5 (E10.5) (Figure 1a, asterisk)3–5 and
subsequently extends caudally along the cloaca reaching the
cloacal membrane. Part of the cloacal membrane degrades
with the approximation of the URS tip. As a result, the cloaca is
divided into the urogenital sinus and rectum, and the tip of the
URS (endodermal epithelia) contributes to forming the
ectodermal epithelia of the perineum and external genitalia.6
The contribution of these cells and growth factors expressed
in the endodermal epithelia are essential for the proper
morphogenesis of the perineal region, based on the
phenotypes of several mutants. For instance, Sonic hedgehog
(Shh) is expressed in the endodermal epithelia and has an
essential role in both URS formation and GT protrusion by
affecting neighboring mesenchymal cells.7–11 Apoptotic cells
are observed in the urogenital tract during URS formation,
being distributed primarily in the epithelial layers of the URS,
cloacal membrane and mesenchyme of the dorsal surface of
the caudal hindgut at E11.5 and E11.75.5,12 From E12.5,
apoptotic cells are also observed in the URS mesenchyme
and are thought to be involved in the transformation of the
URS and disintegration of the cloacal membrane.5
Several congenital anomalies are frequently observed
during urogenital organ development. These abnormalities
are usually accompanied by deficient excretory and copula-
tory functions, influencing the quality of life of the patient.
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In particular, the incidence of anorectal malformations (ARMs)
is approximately 1 in 5000 human births;13 however, the
underlying pathogenic mechanisms of this condition are
currently unknown. ARM phenotypes are observed in several
diseases, including Currarino syndrome, Townes Brocks
syndrome and VACTERL complex.14–17 Affected patients
often display other malformations, such as anal fistulas, sacral
malformations and renal malformations. Human and mouse
genetic analyses have shed light on the possible genetic
causes of some of these abnormalities.
Several mouse mutants for hedgehog signaling genes,
ephrin-Eph signaling genes, fibroblast growth factor (Fgf)
signaling genes and Wnt signaling genes are reported to
display ARM phenotypes.18–22 Another causative factor for
the development of ARM is all-trans retinoic acid (RA), a
teratogen and active form of vitamin A. RA treatment in
pregnant mice results in imperforate anus in embryos.23,24
Although these reports have identified causative factors for
ARM phenotypes, the pathogenic mechanisms underlying the
development of ARM and URS remain elusive.
The Wnt signaling pathway is essential for embryonic
development, and its dysregulation has been implicated in
developmental disorders and human diseases. Wnt signaling
is transmitted primarily via three divergent pathways: the
canonical Wnt/b-catenin pathway, the planner cell polarity
pathway and the Wnt/Ca2þ pathway.25,26 b-Catenin is a key
factor for the canonical Wnt pathway and also acts as a
subunit of the cadherin protein complex, which controls cell–
cell adhesion. Owing to the early lethality of b-catenin-
deficient mice,27 analyses of the function of b-catenin in
organogenesis have been performed using conditional
mutants. Previous reports have revealed that b-catenin
induces the differentiation of hair follicles during hair/skin
development according to loss- and gain-of-function (LOF and
GOF) approaches.28,29 The ectopic activation of canonical
Wnt signaling results in the ectopic induction of bone
morphogenetic protein (Bmp) signaling, which is essential
for hair follicle formation.30,31 With respect to genital tubercle
(primordia of external genitalia: GT) development, region-
specific (ectodermal, endodermal and mesenchymal) mod-
ulation of the b-catenin gene has revealed essential functions,
such as regulation of cell proliferation, epithelial integrity and
protrusion/elongation of GT.8,32,33 However, the regulatory
functions of the b-catenin gene during the development of the
URS have not been investigated.
The current study aimed to investigate the function of
the b-catenin gene in URS development. We modulated the
b-catenin activity in the endodermal epithelia and studied the
phenotypic consequences of dysregulated endodermal
b-catenin signaling for urorectal development. Both b-catenin
Figure 1 Temporally labeled Shh-expressing URS endodermal cells contribute to the ectodermal epithelia. The expression of the Shh gene in sagittal sections of wild-type
embryos at E10.5, E11.5, E12.5 and E13.5 (a–d). The asterisk in (a) indicates future URS derived from the proximal umbilical mesenchyme. Ventral view of the genital tubercle
(e–j). Tissue labeling experiments of Shh-expressing cells were performed at E15.5. ShhCreERT2/þ ; R26LacZ/þ embryos subsequent to TM administration at E8.5, E9.5,
E10.5, E11.5, E12.5 or E13.5 (e–j). The red arrows indicate the LacZ-positive ectodermal cells. b-Catenin was expressed in the endoderm, including the URS epithelia, at
E11.5 in the wild-type embryos (k). b, Bladder; c, cloaca; gt, genital tubercle; hl, hindlimb; r, rectum; t, tail; uc, umbilical cord; urs, urorectal septum
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LOF and GOF mutations resulted in ARM phenotypes.
The b-catenin GOF mutation led to the ectopic induction of
Bmp signaling. Moreover, the ARM phenotypes in the
b-catenin GOF mutants were restored by additionally introdu-
cing the BmprIA gene mutation. These results suggest that
adequately controlled b-catenin signaling and its downstream
growth factor signaling are essential for proper URS formation.
Results
Genetic tissue lineage analyses revealed the temporally
specific contribution of URS epithelia to ectodermal
epithelia. We first studied the kinetics of the contribution of
URS epithelial cells. We utilized ShhCreERT2 mice, which are
knock-in mice of the tamoxifen (TM)-inducible form of Cre
recombinase to the Sonic hedgehog (Shh) locus.34 The Shh
gene was expressed in the endodermal epithelia at
E10.5–13.5 (Figures 1a–d). We crossed ICR female mice
with ShhCreERT2/þ ; R26LacZ/LacZ male mice. The pregnant
females were subsequently treated with TM at E8.5–13.5,
and the embryos were analyzed at E15.5 (Figures 1e–j).
There were few LacZ-positive cells in the perineal epithelia,
urethra and rectum in the embryos upon TM treatment at
E8.5 (Figure 1e). In contrast, numerous LacZ-positive cells
were observed in the perineal epithelia, urethra and rectum in
the embryos with E9.5 or E10.5 treatment (Figures 1f and g,
red arrows). We observed a reduced number of LacZ-
positive cells in the perineal ectodermal epithelia following
later stage TM treatment, such as at E11.5 and E12.5
(Figures 1h and i). Following E13.5 TM treatment, the
perineal epithelia were not positive for LacZ signals
(Figure 1j). These results indicate that the Shh-positive
endodermal epithelia labeled by E9.5–10.5 TM treatment can
primarily contribute to the perineal epithelium.
ARMs were induced by abnormal b-catenin activity. We
then asked whether b-catenin regulates URS formation.
We first analyzed the expression of b-catenin using
immunohistochemistry. The b-catenin expression was
detected in the endoderm, including the URS epithelia, in
the wild-type embryos at E11.5 (Figure 1k). We next used the
ShhCreERT2 system to either constitutively activate or inhibit
the b-catenin activity in the endodermal epithelia and studied
the effects of dysregulated endodermal b-catenin signaling
on URS development.
b-Catenin floxed mutant mice (b-cateninflox), which contain
two loxP sites flanking exons 3–6,28 were crossed to
ShhCreERT2, and conditional deletion of b-catenin in the URS
epithelia was achieved with TM treatment. ShhCreERT2/þ ;
b-cateninflox/ (b-catenin LOF) mutants were analyzed at
E18.5 subsequent to TM treatment at E9.5, E11.5 or E13.5
(Figures 2b–d and b0–d0). The formation of the URS was
perturbed by early-stage TM treatment. The mutants treated
with TM at E9.5 displayed cleft-like phenotypes in the perineal
region (Figures 2b and b0, red arrowheads). In addition, anal
stenosis was observed in the E9.5-TM-treated mutants
Figure 2 Both the LOF and GOF mutants for the b-catenin gene displayed ARM phenotypes. Ventral view of the genital tubercle region (a–g) and sagittal sections of the
embryos at E18.5 (a0–g0). The b-catenin LOF embryos at E18.5 subsequent to TM administration at E9.5 (b and b0), E11.5 (c and c0) and E13.5 (d and d0). The b-catenin GOF
embryos at E18.5 subsequent to TM administration at E9.5 (e and e0), E11.5 (f and f0) and E13.5 (g and g0). The red arrowheads indicate the cleft phenotype of the perineal
region. gt, genital tubercle; r, rectum; t, tail; u, urethra
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(Figure 2b0). TM treatment at E11.5 resulted in hypospadias-
like phenotypes, although no perineal clefts were observed
(Figures 2c and c0). The perineal region in the E13.5-TM-
treated embryos appeared to be normal (Figures 2d and d0).
We further analyzed the differentiation of the perineal
epithelial cells in the E9.5-TM-treated mutants. The expres-
sion of keratin 1 (a marker of prickle cells) and filaggrin
(a marker of granule cells) was analyzed (Figures 3a–e). The
perineal epithelia of the wild-type embryos expressed both
markers at E18.5 (Figures 3a and d, red arrowheads). The
expression of these markers was also observed in the
perineal epithelia of the E9.5-TM-treated b-catenin LOF
mutants (Figures 3b and e, blue arrowheads), indicating that
the differentiation of the URS epithelial cells in the b-catenin
LOF mutants proceeded normally.
Next, a constitutively active b-cateninflox(ex3) mutant allele
was analyzed to determine whether the enhanced b-catenin
activity affects the formation of the URS. The Cre
activity derived from the ShhCreERT2 allele regulated by TM
treatment at E9.5, E11.5 or E13.5 induced a constitutively
active b-catenin lacking the N-terminal domain phosphoryla-
tion sites essential for its degradation (Figures 2e–g and
e0–g0). An augmentation of b-catenin expression and its
activity as a component of Wnt/b-catenin signaling in
E9.5-TM-treated b-catenin GOF mutants were assessed by
immunohistochemistry and transgenic reporter, respectively
(Supplementary Figures S1a–f). Similar to that observed
in the b-catenin LOF mutants, early TM treatment resulted in
hypoplasia during URS/perineal formation in the b-catenin
GOF mutants (Figures 2e, f, e0 and f0, red arrowheads). The
URS in the E9.5-TM-treated mutants did not reach to the
cloacal membrane, leading to incomplete cloacal division of
the urogenital sinus and rectum (Figures 2e and e0). This
phenotype was slightly milder in the E11.5-TM-treated
mutants and was not observed in the E13.5-TM-treated
mutants (Figures 2f, g, f0 and g0). The expression of keratin 1
and filaggrin was also examined in the b-cateninGOFmutants
(Figures 3c and f). Expression of these markers was not
detected in the perineal epithelial region in the E9.5-TM-
treated mutants (Figures 3c and f, demarcated by blue
squares). These results suggest that the GOF b-catenin
mutation perturbs the cell differentiation of the URS epithelium
and that the proper dose of b-catenin activity in the URS
epithelium at early embryonic stages is essential for the
formation of the URS.
Defective cell proliferation of URS mesenchymal cells
may contribute to the abnormal URS formation of
b-catenin mutants. To analyze cellular mechanisms indu-
cing mutant phenotypes, we next performed cell proliferation
Figure 3 The analyses of the differentiation marker expression and cell proliferation in the URS/perineum of the b-catenin LOF and GOF mutants. Sagittal sections of
the wild-type (a and d), b-catenin LOF (b and e) and b-catenin GOF (c and f) embryos. The expression of keratin 1 (a–c) and filaggrin (d–f) was assessed. Both markers were
positive in perineal epithelia of wild-type embryos (red arrowheads) and in URS epithelia of b-catenin LOF embryos (blue arrowheads). The tissues surrounded by blue
squares indicate the URS region (c and f). Cell proliferation was assessed using a BrdU incorporation assay (g–k). Sagittal sections of the wild-type (g), b-catenin LOF (h) and
b-catenin GOF embryos (i) at E11.5. The red squares of the lower magnification pictures indicate magnified areas of (g–k). In the b-catenin LOF mutants, the cell proliferation
of the URS mesenchyme was decreased at E11.5 (h). The cell proliferation in URS epithelia was increased in the b-catenin GOF mutants at E11.5 (i). Sagittal sections of the
wild-type and b-catenin GOF mutants at E13.5 (j and k). The cell proliferation in the mesenchyme of the URS in the b-catenin GOF mutants was decreased (k). c, cloaca;
gt, genital tubercle; r, rectum; u, urethra; urs, urorectal septum
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and death analyses in the E9.5-TM-treated b-catenin LOF
and GOF mutants. The b-catenin LOF mutants displayed
hypoplastic URS and markedly reduced cell proliferation of
the URS mesenchyme at E11.5 (Figure 3h). Decreased
mesenchymal cell proliferation was also observed at
E13.5 using phosphohistone H3 (pHH3) immunostaining
(Supplementary Figure S2). However, the cell proliferation of
the URS epithelia was comparable with that observed in the
controls (Figure 3h). On the other hand, the b-catenin GOF
mutants displayed hypertrophy and an increased number of
cell proliferation in the URS epithelia at E11.5 (Figure 3i).
This hypertrophic layer was confirmed to be derived from
endodermal epithelia using labeling with the ShhCreERT2
system (Supplementary Figure S3). As for the mesenchymal
cell proliferation in the URS, the b-catenin GOF mutants did
not display marked alteration at E11.5 (Figure 3i); however,
cell proliferation was decreased at E13.5 (Figure 3k).
Moreover, we also analyzed the cell death status to
judge whether the apoptotic cells were prominent enough
to induce elongation defects of the URS in both mutants. The
distribution of apoptotic cells in the URS mesenchyme was
not increased in either the b-catenin LOF or GOF mutants at
E11.5 and E13.5 (Figures 4f and h; Supplementary Figure
S4). These results suggest that the reduced cell proliferation
of the URS mesenchyme observed in both the b-catenin LOF
and GOF mutants possibly contributes to defective URS
elongation.
Of note, the b-catenin GOF mutants displayed less
apoptotic cells in the URS epithelia compared with the
controls at E11.5 and E12.5 (Figures 4a, b, f, g, k, l, p and
q, red arrows and surrounded by red dotted line). This reduced
amount of cell death and increased level of cell proliferation
possibly resulted in hypertrophy of the URS epithelia at E11.5
(Figure 3i). Subsequently, at E13.5 and later embryonic
stages, augmented apoptotic cells were observed in the
hypertrophic URS epithelia of the b-catenin GOF mutants
(Figures 4c–e, h–j, m–o and r–t, blue arrows and surrounded
by blue dotted line). Such elevated URS epithelial apoptosis
may contribute to the lack of differentiation of perineal epithelial
cells in the b-catenin GOF mutants (Figures 3c and f).
Ectopic induction of Bmp signaling may contribute to
ARM phenotypes in b-catenin GOF mutants. Next, we
investigated possible causes of the ARM phenotype in
the b-catenin GOF mutants. Several previous reports have
demonstrated the ectopic activation of Bmp signaling in
ectodermal b-catenin GOF mutants.31,32 We therefore
analyzed the expression of several Bmp signaling-related
molecules in the b-catenin GOF mutants. The expression of
the Bmp4 gene was observed in the mesenchyme of the
URS in the wild-type embryos at E13.5 (Figure 5a). The
Bmp4 gene expression was ectopically observed in the URS
epithelia, in addition to the URS mesenchyme, in the
b-catenin GOF mutants (Figure 5e, red arrowheads). The
ectopic expression of Bmp7 was also observed in the URS
epithelia (Figures 5b and f, red arrowheads). We also
analyzed the downstream molecules of Bmp signaling. One
of the downstream genes of Bmp signaling, Msx2, was
ectopically expressed in the URS epithelia (Figures 5c and g,
red arrowheads). Moreover, the expression of phosphory-
lated Smad (pSmad)1/5/8 was increased in both the epithelia
and mesenchyme of the mutant URS (Figures 5d and h, red
arrowheads).
To further ascertain the contribution of ectopic Bmp
signaling in the abnormal development of the URS in the
b-catenin GOF mutants, we analyzed the URS development
in compound mutants for the b-catenin GOFmutation and one
of the Bmp receptors (BmprIA). Although the compound
mutants (ShhCreERT2/þ ; b-cateninflox(ex3)/þ ; BmprIAflox/ )
displayed the perineal cleft, URS elongation was substantially
reversed in these mutants compared with that observed in the
ShhCreERT2/þ ; b-cateninflox(ex3)/þ mutants under E9.5-TM
administration (Figures 5i–k and k0, blue arrowhead). These
results may suggest that the ectopically induced endodermal
Figure 4 Time-course expression analysis of TUNEL and cleaved caspase-3 in the b-catenin GOF mutants. Sagittal sections of the embryos at E11.5, E12.5, E13.5,
E14.5 and E15.5 subsequent to E9.5-TM treatment (a–t). The number of apoptotic cells in the URS epithelia of the b-catenin GOF mutants was less than that observed in the
controls at E11.5 and E12.5 (a, b, f, g, k, l, p and q; red arrows and surrounded by red dotted line). The number of apoptotic cells was increased in the mutant URS epithelia at
E13.5, and such cells were also observed in the mutant URS at E14.5 and E15.5 (c–e, h–j, m–o and r–t; blue arrows and surrounded by blue dotted line). urs, urorectal septum
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Bmp signaling by augmented b-catenin signaling partly
contributes to the ARM phenotypes of b-catenin GOF
mutants.
Discussion
ARM is one of the most frequently observed congenital
diseases in humans. However, the pathogenic mechanisms of
ARM, including the developmental mechanisms of the URS, a
key structure for the formation of the urogenital sinus and
rectum, have not been elucidated. The current analysis
demonstrated perineal clefts and deficient URS elongation
phenotypes in both b-catenin LOF and GOF mutants. In the
case of human ARMs, there are several types of symptoms.35
Focusing on the location of the anal opening, the phenotype of
b-catenin LOF mutants may be similar to perineal fistulas, a
benign type of ARM. In contrast, the phenotype of b-catenin
GOFmutants may be similar to a severe type of ARM, namely
rectourethral bulbar fistulas, abnormal communications or
fistulas, between the rectum and urinary tract. These
classifications are usually thought to reflect the severity of
symptoms, presumably because of the different pathogenic
causes.
b-Catenin is expressed in the normal URS epithelia.
b-Catenin LOF mutants displayed decreased cell proliferation
in the URS mesenchyme. This is considered to affect directly
to the size of the URS. b-Catenin is essential for inducing the
expression of several growth factors in the gut endoderm,
including the small intestine.36,37 Likewise, the b-catenin
expressed in the URS epithelium may affect downstream
growth factor signals. The regulation of mesenchymal
development is known to occur via the actions of endoder-
mally derived growth factors, such as Shh. It has also been
suggested thatShh positively regulates the cell proliferation of
URS mesenchymal cells.7 The level of b-catenin in the
endodermal epithelia is reduced in Shh-null mutants, and the
Shh expression is reduced in b-catenin conditional mutants.8
These previous results suggest the possibility of the reduction
of downstream growth factor signaling associated with
reduced cell proliferation in b-catenin LOF mutants. The
current results suggest that growth factor signaling, including
b-catenin, can regulate URS elongation by affecting URS
mesenchymal cell proliferation.
On the other hand, the b-catenin GOF mutants also
displayed ARM phenotypes. In this study, we focused on the
ectopic induction of Bmp signaling in the URS epithelia and
mesenchyme and found that the ARM phenotypes of the
b-catenin GOF mutants were partly restored by the additional
mutation of Bmp signaling. In addition, previous reports have
suggested that the ectopic induction of b-catenin signaling
can induce the ectopic Fgf8 expression in the cloacal
endoderm.8,11,32 These findings may indicate that the ectopic
induction of several growth factors perturbs proper URS
development. We also observed transiently reduced apopto-
sis and subsequently increased apoptosis in the URS
epithelium in the b-catenin GOF mutants. Such continuous
cell death may affect the maturation of the URS epithelia and
contribute to phenotypic differences between b-catenin LOF
and GOF mutants.
In support of these findings, null mutants of the
Wnt inhibitory factor 1 (Wif1) gene, which is primarily
expressed at the apical URS endoderm and cloacal
membrane, displayed urorectal defects, and the exogenous
addition of Wif1 proteins in an urorectal culture caused
cloacal membrane disintegration (Ng et al.38). Our results
demonstrate that spatiotemporally and properly controlled
levels of URS epithelial b-catenin signaling are essential
for cloacal septation and that dysregulation of endodermal
b-catenin signaling leads to abnormal downstream
growth factor activity. The current results are considered
Figure 5 Ectopic Bmp signaling in the epithelia of the URS in the E9.5-TM-treated b-catenin GOF mutants. Sagittal sections of the embryos at E13.5 (a–h). The
expression of Bmp4 and Bmp7 was increased in the mutant URS epithelium (e and f). Msx2, a downstream target of Bmp signaling, and pSmad1/5/8 were ectopically induced
(g and h). The red arrowheads indicate ectopic induction of the gene and protein expression (e–h). Sagittal sections of the wild-type, ShhCreERT2/þ ; b-cateninflox(ex3)/þ ,
ShhCreERT2/þ ; b-cateninflox(ex3)/þ ; BmprIAflox/ embryos at E18.5 subsequent to E9.5-TM treatment (i–k). Ventral view of a ShhCreERT2/þ ; b-cateninflox(ex3)/þ ; BmprIAflox/
embryo (k0). The URS abnormality was partly restored in the ShhCreERT2/þ ; b-cateninflox(ex3)/þ ; BmprIAflox/ mutants compared with that observed in the ShhCreERT2/þ ;
b-cateninflox(ex3)/þ mutants (j and k). The blue arrowhead indicates the tip of the URS. gt, genital tubercle; r, rectum; t, tail; u, urethra; urs, urorectal septum
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to contribute to the better understanding of the pathogenesis
of ARM.
Materials and Methods
Mice. The mutant mice used in this study were ShhCreERT2, Rosa26R (R26LacZ),
b-cateninflox, b-cateninflox(ex3), BmprIAflox, TopGAL and CAG-Cre.28,34,36,39–42 The
genotypes of each strain were determined as reported previously. To obtain
ShhCreERT2/þ ; R26LacZ/þ mice, ShhCreERT2/þ ; R26LacZ/LacZ male and Jcl:ICR
(CLEA Japan, Osaka, Japan) female mice were crossed. The BmprIA-null allele
(BmprIAþ / ) was generated using BmprIAflox and CAG-Cre driver mice.41 The
mouse embryos were processed for X-gal or immunohistochemical staining. Noon
of the day on which the vaginal plug appeared was designated as E0.5. All
experimental procedures and protocols were approved by the Committees on
Animal Research at Wakayama Medical University and Kumamoto University.
Histological analyses. The mouse embryos were fixed overnight in 4%
paraformaldehyde (Sigma-Aldrich, Tokyo, Japan) with PBS, dehydrated with
methanol and embedded in paraffin. Then, 6-mm serial sections were prepared.
Hematoxylin and eosin staining was performed using standard procedures. X-gal
staining was carried out as described previously.43 The X-gal-stained samples
were embedded in paraffin and sectioned. The immunohistochemical analysis was
performed according to standard procedures using anti-b-catenin antibodies
(1 : 100; BD Biosciences, Tokyo, Japan), anti-cleaved caspase-3 (Asp175)
antibodies (1 : 1000; Cell Signaling Technology, Tokyo, Japan), anti-keratin 1
antibodies (1 : 200; Covance, Tokyo, Japan), anti-filaggrin antibodies (1 : 300;
Covance), anti-pSmad1/5/8 antibodies (1 : 300; Cell Signaling Technology) and
anti-pHH3 (Ser10) antibodies (1 : 1000; Merck Millipore, Tokyo, Japan). Signal
amplification was performed using the appropriate VECTASTAIN ABC IgG Kit
(Vector Laboratories, Burlingame, CA, USA), and the immunocomplexes were
detected with DAB staining. For the cell proliferation assays, pregnant females
were injected with 100 mg of 5-bromo-2’-deoxyuridine (BrdU; Sigma-Aldrich) per
kg of body weight. One hour after injection, the embryos were collected and
processed for immunohistochemistry with anti-BrdU antibodies (1:300; Roche,
Mannheim, Germany). For the cell death analyses, a TUNEL assay was
performed with the In situ Apoptosis Detection Kit (Takara, Ohtsu, Japan).
RNA in situ hybridization. Section in situ hybridization for the gene
expression analyses was performed as described previously.44 The antisense
riboprobe templates have been described previously: Shh (kindly provided by
Dr. C Shukunami, Hiroshima, Japan), Bmp4,45 Bmp7 (kindly provided by Dr. M
Yoshida, Kobe, Japan) and Msx2 (kindly provided by Dr. Hill RE, Edinburgh, UK
and Dr. I Satokata, Niigata, Japan).
TM administration for conditional gene recombination. The TM-
inducible Cre recombinase system removes the floxed sequence from the target
genome.46–48 A 10 mg/ml stock solution of TM (T-5648; Sigma-Aldrich) was
prepared in sesame oil.8 The pregnant females received 0.1 mg of TM per g of
maternal body weight intraperitoneally at the indicated time points. No overt
teratological effects were observed under these conditions.8,43,49
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